Search Press releases Keywords From To 15 Sep 2017 New indication for BRIVIACT® (brivaracetam): UCB’s newest antiepileptic drug approved by FDA as monotherapy treatment of partial-onset seizures in adults Read More 14 Sep 2017 New CIMZIA® (certolizumab pegol) Findings Presented at European Academy of Dermatology and Venereology (EADV) Congress Read More 11 Sep 2017 EVENITYTM (romosozumab) ARCH Study Results Published in the New England Journal of Medicine Read More 7 Sep 2017 UCB highlights latest EVENITY™ (romosozumab) research at the American Society for Bone and Mineral Research Annual Meeting Read More 23 Aug 2017 Transparency notification Wellington Read More 2 Aug 2017 Transparency notification The Capital Group Companies Read More Pagination First page Previous page Previous … Page 75 Page 76 Page 77 Page 78 Current page 79 Page 80 Page 81 Page 82 Page 83 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
